MiR-338-3p inhibited the invasion and migration of NSCLC cells through the suppression of EMT-related transcription factor Sox4 and might serve as a potential therapeutic target for NSCLC [52]. This evidence concerns the gene SOX4 and non-small cell lung carcinoma.